Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis (Q35766646)

10 August 2017

Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis (English)

1 reference

juvenile rheumatoid arthritis

10 August 2017

1 reference

inferred from title

pulmonary hypertension

1 reference

Karen Onel

14

0 references

Jordi Anton

object named as

Jordi Antón

9

0 references

Nico M Wulffraat

19

object named as

Nico Wulffraat

1 reference

10 August 2017

Yukiko Kimura

1

1 reference

10 August 2017

Jennifer E Weiss

2

1 reference

10 August 2017

Kathryn L Haroldson

3

1 reference

10 August 2017

Tzielan Lee

4

1 reference

10 August 2017

Marilynn Punaro

5

1 reference

10 August 2017

Sheila Oliveira

6

1 reference

10 August 2017

Egla Rabinovich

7

1 reference

10 August 2017

Meredith Riebschleger

8

1 reference

10 August 2017

Peter R Blier

10

1 reference

10 August 2017

Valeria Gerloni

11

1 reference

10 August 2017

Melissa M Hazen

12

1 reference

10 August 2017

Elizabeth Kessler

13

1 reference

10 August 2017

Murray H Passo

15

1 reference

10 August 2017

Robert M Rennebohm

16

1 reference

10 August 2017

Carol A Wallace

17

1 reference

10 August 2017

Patricia Woo

18

1 reference

10 August 2017

Childhood Arthritis Rheumatology Research Alliance Carra Net Investigators

20

1 reference

10 August 2017

language of work or name

1 reference

1 May 2013

1 reference

Arthritis Care and Research

10 August 2017

1 reference

10 August 2017

65

1 reference

10 August 2017

5

1 reference

10 August 2017

745-752

1 reference

Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Mortality outcomes in pediatric rheumatology in the US.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Anakinra for systemic juvenile arthritis: the Rocky Mountain experience

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Molecular pathogenesis of pulmonary arterial hypertension

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Macrophage activation syndrome in juvenile idiopathic arthritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Development of progressive pulmonary interstitial and intra-alveolar cholesterol granulomas (PICG) associated with therapy-resistant chronic systemic juvenile arthritis (CJA).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

A case of adult Still's disease with pulmonary hypertension

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

A 21-year-old man with systemic-onset juvenile rheumatoid arthritis, cough and progressive dyspnea.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476507

Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FACR.21889

Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FACR.21889

Chemokine RANTES in Severe Pulmonary Arterial Hypertension

21 January 2018

1 reference

12 December 2020

Is macrophage activation syndrome a new entity?

1 reference

12 December 2020

Macrophage activation syndrome--what's in a name!

1 reference

12 December 2020

Primary pulmonary hypertension in a patient with systemic-onset juvenile arthritis

1 reference

12 December 2020

Interstitial lung disease and adult-onset Still's disease

1 reference

12 December 2020

Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis

1 reference

12 December 2020

Inflammation in Pulmonary Arterial Hypertension

1 reference

12 December 2020

Pulmonary arterial hypertension complicating adult-onset Still's disease

1 reference

12 December 2020

Pulmonary hypertension in a patient with adult-onset Stills disease

1 reference

12 December 2020

Identifiers

DOI

10.1002/ACR.21889

1 reference

10 August 2017

1 reference

10 August 2017

1 reference